Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?

Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy. Eur Radiol (2014) 0.77

Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiat Oncol (2015) 0.75

Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. Radiother Oncol (2007) 1.47

Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol (2012) 1.17

Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One (2008) 1.17

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys (2002) 1.16

Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One (2011) 1.08

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Cancer Res (2009) 1.08

Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer (2010) 1.03

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys (2005) 1.02

Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol (2012) 0.99

Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model. J Transl Med (2013) 0.94

Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset. Int J Oncol (2012) 0.90

Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis. J Transl Med (2012) 0.90

Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. J Clin Oncol (2009) 0.90

Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse? Breast (2002) 0.89

Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody. Virchows Arch (2003) 0.88

The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol (2012) 0.86

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy. Gynecol Oncol (2006) 0.85

Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique. Gynecol Oncol (2008) 0.84

Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages. Cancer Lett (2012) 0.83

Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group. Cancer (2005) 0.81

Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for stage IB1 adenocarcinoma of the cervix. J Minim Invasive Gynecol (2008) 0.81

Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy. Radiother Oncol (2012) 0.80

[Preservation of fertility in gynaecologic cancers]. Bull Cancer (2008) 0.79

Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women: analysis of 927 cases. Crit Rev Oncol Hematol (2008) 0.79

Breast-conserving therapy for stage I-II breast cancer in elderly women. Int J Radiat Oncol Biol Phys (2004) 0.78

GERICO-03 phase II trial of accelerated and partial breast irradiation in elderly women: feasibility, reproducibility, and impact on functional status. Brachytherapy (2013) 0.78

Prognostic relevance of celiac lymph node involvement in ovarian cancer. Int J Gynecol Cancer (2014) 0.76

Early stage (IA-IB) primary carcinoma of the fallopian tube: case-control comparison to adenocarcinoma of the ovary. J Gynecol Oncol (2011) 0.75

Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer. PLoS Genet (2016) 0.75

Pitfalls of CA-125 levels in the preoperative work-up of ovarian masses. J Clin Oncol (2008) 0.75

Peritoneal pseudomyxoma arising from the urachus. Surg Oncol (2010) 0.75

A comparative study of laparoscopic extraperitoneal lymphadenectomy [correction of laparoscopy] with the use of ultrasonically activated shears. Am J Obstet Gynecol (2009) 0.75

Inter-clinician variability in making dosimetric decisions in pediatric treatment: a balance between efficacy and late effects. Radiother Oncol (2009) 0.75

[Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor]. Bull Cancer (2006) 0.75

Mapping of critical source areas for diffuse fecal bacterial pollution in extensively grazed watersheds. Water Res (2010) 0.75

Adherence to guidelines in gynecologic cancer surgery. Int J Gynecol Cancer (2014) 0.75

Spontaneous regression of peritoneal carcinomatosis in a borderline ovarian tumour. Eur J Obstet Gynecol Reprod Biol (2008) 0.75

[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer]. Bull Cancer (2009) 0.75